MMJ Phytotech (ASX:MMJ) is preparing to provide an update on its CBD (Cannabidiol) pill, with the ASX granting the company a trading halt to prepare.
The company recently raised $4.8 million and has previously said that it is expecting revenues from CBD pill sales.
Earlier in the month MMJ's subsidiary, PhytoTech Therapeutics, received official National approval in Israel to commence a Phase I Clinical Study to assess the safety and performance of its proprietary oral capsule formulations.
PhytoTech Therapeutics intends to commence the study by November 2015, with initial results expected as early as Q1 2016.
The halt will remain in place until the opening of trade on Monday 31st August 2015, or earlier if an announcement is made to the market.
- Forums
- ASX - By Stock
- HGV
- News: MMJ Phytotech to update on Cannabidiol pill
News: MMJ Phytotech to update on Cannabidiol pill
-
- There are more pages in this discussion • 128 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HGV (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.412M |
Open | High | Low | Value | Volume |
4.0¢ | 4.0¢ | 4.0¢ | $1.402K | 35.05K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 366715 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.4¢ | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 366715 | 0.040 |
2 | 215461 | 0.039 |
1 | 135135 | 0.035 |
1 | 40000 | 0.034 |
1 | 30303 | 0.033 |
Price($) | Vol. | No. |
---|---|---|
0.044 | 10000 | 1 |
0.045 | 60000 | 1 |
0.047 | 20000 | 1 |
0.049 | 130000 | 2 |
0.050 | 52267 | 2 |
Last trade - 15.54pm 13/09/2024 (20 minute delay) ? |
Featured News
HGV (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online